Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
by
Wolters, Eric Ch
, van der Werf, Ysbrand D.
, van den Heuvel, Odile A.
in
Antiparkinson Agents - adverse effects
/ Disruptive, Impulse Control, and Conduct Disorders - chemically induced
/ Disruptive, Impulse Control, and Conduct Disorders - physiopathology
/ Dopamine - metabolism
/ Gambling - psychology
/ Humans
/ Impulsive Behavior - chemically induced
/ Impulsive Behavior - metabolism
/ Impulsive Behavior - pathology
/ Medicine
/ Medicine & Public Health
/ Neurology
/ Neuroradiology
/ Neurosciences
/ Parkinson Disease - drug therapy
/ Parkinson Disease - metabolism
/ Parkinson Disease - pathology
/ Parkinson Disease - physiopathology
/ Parkinson's disease
2008
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
by
Wolters, Eric Ch
, van der Werf, Ysbrand D.
, van den Heuvel, Odile A.
in
Antiparkinson Agents - adverse effects
/ Disruptive, Impulse Control, and Conduct Disorders - chemically induced
/ Disruptive, Impulse Control, and Conduct Disorders - physiopathology
/ Dopamine - metabolism
/ Gambling - psychology
/ Humans
/ Impulsive Behavior - chemically induced
/ Impulsive Behavior - metabolism
/ Impulsive Behavior - pathology
/ Medicine
/ Medicine & Public Health
/ Neurology
/ Neuroradiology
/ Neurosciences
/ Parkinson Disease - drug therapy
/ Parkinson Disease - metabolism
/ Parkinson Disease - pathology
/ Parkinson Disease - physiopathology
/ Parkinson's disease
2008
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
by
Wolters, Eric Ch
, van der Werf, Ysbrand D.
, van den Heuvel, Odile A.
in
Antiparkinson Agents - adverse effects
/ Disruptive, Impulse Control, and Conduct Disorders - chemically induced
/ Disruptive, Impulse Control, and Conduct Disorders - physiopathology
/ Dopamine - metabolism
/ Gambling - psychology
/ Humans
/ Impulsive Behavior - chemically induced
/ Impulsive Behavior - metabolism
/ Impulsive Behavior - pathology
/ Medicine
/ Medicine & Public Health
/ Neurology
/ Neuroradiology
/ Neurosciences
/ Parkinson Disease - drug therapy
/ Parkinson Disease - metabolism
/ Parkinson Disease - pathology
/ Parkinson Disease - physiopathology
/ Parkinson's disease
2008
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
Journal Article
Parkinson’s disease-related disorders in the impulsive-compulsive spectrum
2008
Request Book From Autostore
and Choose the Collection Method
Overview
In Parkinson’s disease (PD), there is increasing evidence for disorders in the impulsive-compulsive spectrum, related to the disease itself, to the pharmacological management of this disease or to both. These disorders comprise dopamine deficiency syndrome (with immediate reward seeking behaviour), dopamine dependency syndrome (with addictive behaviour), dopamine dysregulation syndrome (with both addictive behaviour and stereotyped behaviour) and impulse control disorders (such as pathological gambling, compulsive shopping, binge eating and hypersexuality). These disorders are especially seen in PD patients with young age of onset, higher doses of antiparkinsonian drugs, pre-existent or current depression, pre-existing recreational drug or alcohol use, and high novelty seeking personality traits.
Dopamine is not only implicated in voluntary movement control but also plays a significant role in the brain’s reward system and the modulation of behaviours. Therefore, most if not all drugnaïve PD patients will suffer dysphoria, leading to mild immediate reward seeking behaviour as a consequence of the striatal dopaminergic denervation. In some of these patients, during treatment, this may even lead to the intake of increasing quantities of levodopa, above those required to adequately treat motor parkinsonism, with all characteristics of a dopamine dependence syndrome. These patients may develop plastic changes in the striatal matrix leading to hyperkinesia, caused by extracellular striatal dopaminergic fluctuations due to pulsatile dopamine replacement therapy. As soon as these changes are also seen in the striatal striosomes, in the framework of a dopamine dysregulation syndrome, stereotyped behaviours (punding) may occur (supposedly due to dorsal versus ventral striatal overactivity). Finally, impulse control disorders are suggested as being pure adverse side-effects of dopamine replacement therapy. Obsessive-compulsive behaviour (caused by ventral to dorsal overactivity) so far has not been described in PD patients.
Treatment of impulse control disorders is related to the underlying pathology. In the case of an intrinsic dopamine deficiency syndrome, treatment with dopamine replacement therapy, especially levodopa, will help. In the multifactorial (intrinsic and extrinsic) dopamine dependency and dysregulation syndromes, addictive behaviour might best be helped by psychosocial strategies, and punding by continuous dopaminergic receptor stimulation (or amantadine), hypothesized to reduce the plastic changes-induced hypersensitization. The extrinsic impulse control disorders might be best treated by reducing or replacing dopamine receptor agonists.
Publisher
D. Steinkopff-Verlag,Springer Nature B.V
Subject
Antiparkinson Agents - adverse effects
/ Disruptive, Impulse Control, and Conduct Disorders - chemically induced
/ Disruptive, Impulse Control, and Conduct Disorders - physiopathology
/ Humans
/ Impulsive Behavior - chemically induced
/ Impulsive Behavior - metabolism
/ Impulsive Behavior - pathology
/ Medicine
/ Parkinson Disease - drug therapy
/ Parkinson Disease - metabolism
/ Parkinson Disease - pathology
This website uses cookies to ensure you get the best experience on our website.